Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Investigators identify cell replacement/tissue repair potential in adult bone marrow stem cells

Investigators identify cell replacement/tissue repair potential in adult bone marrow stem cells

Nottingham scientists to develop world's first atlas of the Asian brain

Nottingham scientists to develop world's first atlas of the Asian brain

Social interventions may help slow or treat age-related dementia

Social interventions may help slow or treat age-related dementia

July issue of Neurosurgery provides update on Human Connectome Project

July issue of Neurosurgery provides update on Human Connectome Project

Cells close to death from toxin exposure can survive when toxins are removed

Cells close to death from toxin exposure can survive when toxins are removed

Botulinum toxin may help prevent arm tremor in people with MS

Botulinum toxin may help prevent arm tremor in people with MS

EvergreenHealth, King County EMS collaborate to prevent future falls among older adults

EvergreenHealth, King County EMS collaborate to prevent future falls among older adults

USPTO issues notice of allowance to Avanir for NUEDEXTA

USPTO issues notice of allowance to Avanir for NUEDEXTA

State roundup: Bumpy managed care transition in Calif.

State roundup: Bumpy managed care transition in Calif.

Hearing loss linked to Alzheimer's, heart disease, chronic kidney diseases and diabetes

Hearing loss linked to Alzheimer's, heart disease, chronic kidney diseases and diabetes

Current diagnosis and treatment approaches for rheumatoid arthritis

Current diagnosis and treatment approaches for rheumatoid arthritis

Chronic inflammation can predispose the brain to develop Alzheimer's disease

Chronic inflammation can predispose the brain to develop Alzheimer's disease

Rapamycin enhances learning and memory in young mice

Rapamycin enhances learning and memory in young mice

FOXO1 gene may play an important role in pathological mechanisms of Parkinson's

FOXO1 gene may play an important role in pathological mechanisms of Parkinson's

Researchers identify genes that influence degeneration of the hippocampus

Researchers identify genes that influence degeneration of the hippocampus

Researchers create 'Huntington's disease in a dish' to enable search for treatment

Researchers create 'Huntington's disease in a dish' to enable search for treatment

Potential risk factors for disorder that causes people to kick or punch during sleep

Potential risk factors for disorder that causes people to kick or punch during sleep

HHS honors UNTHSC, Brookdale Senior Living with $7.3M Health Care Innovation award

HHS honors UNTHSC, Brookdale Senior Living with $7.3M Health Care Innovation award

New compound could treat certain types of genetic disorders in muscles

New compound could treat certain types of genetic disorders in muscles

Humanetics receives U.S. patent for NIC5-15 to treat Alzheimer's

Humanetics receives U.S. patent for NIC5-15 to treat Alzheimer's

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.